Artecan Artesunate 60 mg Injection – Product Description Artecan Artesunate 60 mg Injection contains Artesunate 60 mg, an antimalarial medicine used in the treatment of malaria, particularly when injectable therapy is required. Artesunate is available as a powder for preparation of an injectable solution, and WHO has prequalified several 60 mg artesunate injection products. Key Features Brand Name: Artecan Active Ingredient: Artesunate 60 mg Strength: 60 mg Dosage Form: Powder for solution for injection Therapeutic Category: Antimalarial Indication: Treatment of malaria; injectable artesunate is especially important in severe malaria management. Administration: Administered by a qualified healthcare professional; do not self-administer. Benefits & Uses Artesunate works rapidly against malaria parasites and is used as part of appropriate antimalarial treatment. For severe malaria, injectable artesunate should be followed by a complete course of an appropriate oral antimalarial regimen. Storage Storage requirements can vary by formulation and manufacturer. WHO-prequalified 60 mg artesunate products are generally stored below 30°C, protected from light, and should not be refrigerated or frozen; always follow the specific product label. Important Safety Information Artecan Artesunate 60 mg Injection should be used only under medical supervision. Possible adverse effects may include headache, dizziness, weakness, appetite changes, and injection-site reactions. Delayed hemolytic anemia has also been reported following injectable artesunate treatment, so appropriate clinical follow-up may be required. Disclaimer: This product description is for informational and promotional purposes. Dosage, reconstitution, route of administration, and treatment duration should be determined by a qualified healthcare professional according to the approved product information.